Barohn R - Search Results

1

Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Graves TD, Cha YH, Hahn AF, Barohn R, Salajegheh MK, Griggs RC, Bundy BN, Jen JC, Baloh RW, Hanna MG; CINCH Investigators. Graves TD, et al. Among authors: barohn r. Brain. 2014 Apr;137(Pt 4):1009-18. doi: 10.1093/brain/awu012. Epub 2014 Feb 26. Brain. 2014. PMID: 24578548 Free PMC article.

2

Andersen's syndrome: a distinct periodic paralysis.

Sansone V, Griggs RC, Meola G, Ptácek LJ, Barohn R, Iannaccone S, Bryan W, Baker N, Janas SJ, Scott W, Ririe D, Tawil R. Sansone V, et al. Among authors: barohn r. Ann Neurol. 1997 Sep;42(3):305-12. doi: 10.1002/ana.410420306. Ann Neurol. 1997. PMID: 9307251 Free article.

3

Diabetic Lumbosacral Polyradiculoneuropathies.

Amato AA, Barohn RJ. Amato AA, et al. Curr Treat Options Neurol. 2001 Mar;3(2):139-146. doi: 10.1007/s11940-001-0049-y. Curr Treat Options Neurol. 2001. PMID: 11180751

4

Challenges in the identification of cobalamin-deficiency polyneuropathy.

Saperstein DS, Wolfe GI, Gronseth GS, Nations SP, Herbelin LL, Bryan WW, Barohn RJ. Saperstein DS, et al. Arch Neurol. 2003 Sep;60(9):1296-301. doi: 10.1001/archneur.60.9.1296. Arch Neurol. 2003. PMID: 12975298

5

Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome.

Wolfe GI, Nations SP, Burns DK, Herbelin LL, Barohn RJ. Wolfe GI, et al. Neurology. 2003 Sep 23;61(6):873; author reply 873. Neurology. 2003. PMID: 14723230 No abstract available.

6

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.

Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA. Greenberg SA, et al. Among authors: barohn rj. Ann Neurol. 2005 May;57(5):664-78. doi: 10.1002/ana.20464. Ann Neurol. 2005. PMID: 15852401

7

A case of late-onset proximal and distal muscle weakness.

Barohn RJ, Watts GD, Amato AA. Barohn RJ, et al. Neurology. 2009 Nov 10;73(19):1592-7. doi: 10.1212/WNL.0b013e3181c0d4cb. Neurology. 2009. PMID: 19901252 No abstract available.

8

The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Burns TM, Conaway M, Sanders DB; MG Composite and MG-QOL15 Study Group. Burns TM, et al. Neurology. 2010 May 4;74(18):1434-40. doi: 10.1212/WNL.0b013e3181dc1b1e. Neurology. 2010. PMID: 20439845 Free PMC article.

9

An interactive voice response diary for patients with non-dystrophic myotonia.

Statland JM, Wang Y, Richesson R, Bundy B, Herbelin L, Gomes J, Trivedi J, Venance S, Amato A, Hanna M, Griggs R, Barohn RJ; Cinch Consortium. Statland JM, et al. Among authors: barohn rj. Muscle Nerve. 2011 Jul;44(1):30-5. doi: 10.1002/mus.22007. Muscle Nerve. 2011. PMID: 21674518 Free PMC article.

10

Facial onset sensorimotor neuronopathy syndrome: a case series.

Dobrev D, Barohn RJ, Anderson NE, Kilfoyle D, Khan S, McVey AL, Herbelin L, Dimachkie MM. Dobrev D, et al. J Clin Neuromuscul Dis. 2012 Sep;14(1):7-10. doi: 10.1097/CND.0b013e31825f82b3. J Clin Neuromuscul Dis. 2012. PMID: 22922575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page